...
首页> 外文期刊>Journal of Medicinal Chemistry >Design, synthesis, and activity of a novel series of factor xa inhibitors: optimization of arylamidine groups(1,2).
【24h】

Design, synthesis, and activity of a novel series of factor xa inhibitors: optimization of arylamidine groups(1,2).

机译:设计,合成和一系列新型的因子xa抑制剂的活性:优化芳酰胺基(1,2)。

获取原文
获取原文并翻译 | 示例
           

摘要

A novel series of diaryloxypyridines have been designed as selective nanomolar factor Xa (fXa) inhibitors for use as anticoagulants. In this paper, we describe our efforts to identify an additional interaction and a replacement for the distal amidine group that binds in the S3/S4 pocket of fXa. Introduction of a hydroxyl group para to the proximal amidine group increases the potency vs fXa by 1-2 orders of magnitude, which is the result of a hydrogen bond to Ser195 of the catalytic triad. A methyl imidazoline and a dimethylamide are good alternatives for the second amidine. These substitutions have increased the selectivity vs the related serine proteases trypsin and thrombin. The synthesis, in vitro activity, and hypothetical modes of binding to fXa based on trypsin crystallographic data are outlined.
机译:已经设计了一系列新颖的二芳基氧基吡啶作为用作抗凝剂的选择性纳摩尔因子Xa(fXa)抑制剂。在本文中,我们描述了我们的工作,以确定与fXa的S3 / S4口袋结合的远端am基团的其他相互作用和替代物。在近端am基团对位引入羟基可使相对于fXa的效价提高1-2个数量级,这是氢与催化三联体的Ser195键合的结果。甲基咪唑啉和二甲基酰胺是第二种idine的良好替代品。与相关的丝氨酸蛋白酶胰蛋白酶和凝血酶相比,这些取代提高了选择性。概述了基于胰蛋白酶晶体学数据的合成,体外活性和与fXa结合的假设模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号